Keros Therapeutics, Inc. Current Assets
Keros Therapeutics, Inc. (KROS) had Current Assets of $266.88 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-03
- 2026-06-30: Assets, Current $266.88M.
- 2026-03-31: Assets, Current $290.68M.
- 2025-12-31: Assets, Current $315.43M.
- 2025-09-30: Assets, Current $719.31M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $266.88M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $290.68M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $315.43M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $719.31M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $732.81M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $759.51M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $588.89M 10-K · filed 2026-03-04 |
| 2024-09-30 | $552.05M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $432.71M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $463.13M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $347.29M 10-K · filed 2025-02-26 |
| 2023-09-30 | $304.44M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $334.31M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $362.22M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $285.77M 10-K · filed 2024-02-28 |
| 2022-09-30 | $245.88M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $222.36M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $231.22M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $251.44M 10-K · filed 2023-03-03 |
| 2021-09-30 | $226.07M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $241.42M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $255.98M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $267.73M 10-K · filed 2022-03-09 |
| 2020-09-30 | $136.42M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $148.52M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $58.54M 10-Q · filed 2020-05-22 |
| 2019-12-31 | $8.93M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |